Company / Free Cash Flow per Share
Sana Biotechnology, Inc. Free Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.11
FY2024
5-year range
-$12.44 / -$1.11
FY2020-FY2024
Trend
+21.0%
vs FY2023
Sector context
#106 of 192
Health Care
What the data says
At $-1.11, Sana Biotechnology, Inc.'s free cash flow per share ranks #106 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 5 consecutive years, from $-22.77 in FY2019 to $-1.11 in FY2024.
Based on SEC 10-K filings.
-1.11 in FY2024.
Improved from $-1.65 to $-1.11 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 192 in Health CareTop 55% of 192This company -$1.11 Sector average -$19.84
▼
+94.4% above sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s free cash flow per share has grown for 5 consecutive years.
- In FY2024, free cash flow per share increased 21.0% year-over-year.
- Ranks #106 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.11 | +21.0% |
| FY2023 | -$1.41 | +14.8% |
| FY2022 | -$1.65 | +2.2% |
| FY2021 | -$1.69 | +86.4% |
| FY2020 | -$12.44 | +45.4% |
| FY2019 | -$22.77 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026